Yuliang Ran
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Cancer-related gene regulation 6
- Angiogenesis and VEGF in Cancer 3
- Oncology 18
- Cancer Cells and Metastasis 8
- Peptidase Inhibition and Analysis 7
- HER2/EGFR in Cancer Research 6
- Co-authors
- Zhuan Zhou (12 shared papers)Lichao Sun (26 shared papers)Mingyuan Gao (2 shared papers)Long Yu (21 shared papers)Lusha Wei (1 shared paper)Zhongrui Li (1 shared paper)Fangqin Hu (1 shared paper)Lixin Sun (16 shared papers)
- Journals
- International Journal of Medical Sciences (3 papers)Clinical Cancer Research (3 papers)Cancer Letters (2 papers)Stem Cell Research & Therapy (2 papers)Journal of Cancer (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yuliang Ran
50 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 272
- Biomaterials 225
- Oncology 277
- Immunology and Allergy 50
- Molecular Biology 555
Countries citing papers authored by Yuliang Ran
This map shows the geographic impact of Yuliang Ran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuliang Ran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuliang Ran more than expected).
Fields of papers citing papers by Yuliang Ran
This network shows the impact of papers produced by Yuliang Ran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuliang Ran. The network helps show where Yuliang Ran may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuliang Ran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 364 | |
| 2 | 2020 | 81 | |
| 3 | 2009 | 71 | |
| 4 | 2011 | 59 | |
| 5 | 2008 | 53 | |
| 6 | 2008 | 49 | |
| 7 | 2017 | 47 | |
| 8 | 2021 | 46 | |
| 9 | 2008 | 44 | |
| 10 | 2021 | 43 | |
| 11 | 2006 | 41 | |
| 12 | 2016 | 36 | |
| 13 | 2018 | 32 | |
| 14 | 2016 | 31 | |
| 15 | CPA4 is a promising diagnostic serum biomarker for pancreatic cancer. | 2016 | 31 |
| 16 | 2009 | 30 | |
| 17 | 2017 | 29 | |
| 18 | 2021 | 27 | |
| 19 | Overexpression of carboxypeptidase A4 (CPA4) is associated with poor prognosis in patients with gastric cancer. | 2016 | 26 |
| 20 | 2019 | 25 |
About Yuliang Ran
Yuliang Ran is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Radiology, Nuclear Medicine and Imaging, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Peptidase Inhibition and Analysis (7 papers), HER2/EGFR in Cancer Research (6 papers), Cancer-related gene regulation (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related molecular mechanisms research (4 papers), Cell Adhesion Molecules Research (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (272 citations), Biomaterials (225 citations), Oncology (277 citations), Immunology and Allergy (50 citations) and Molecular Biology (555 citations). Yuliang Ran has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhuan Zhou, Lichao Sun, Mingyuan Gao, Long Yu, Lusha Wei, Zhongrui Li, Fangqin Hu, Lixin Sun, Zhihua Yang and Zhihua Yang. Their work appears in journals such as International Journal of Medical Sciences, Clinical Cancer Research, Cancer Letters, Stem Cell Research & Therapy and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.